Dr. Andrea Hawe

Dr. Andrea Hawe is Chief Scientific Officer at Coriolis. She is an expert in drug product development for biologics with a strong scientific background in protein formulation, surfactant and particle characterization, as well as lyophilization process technology. Andrea has published more than 40 peer-reviewed papers and book chapters.

At Coriolis Andrea is responsible for Science & Technology in close collaboration with Dr. Tim Menzen. She also leads the Coriolis’ Scientific Advisory Board. Together with the Scientific Advisors, and her internal team of Scientific Reviewers, Andrea supports the Business Development and Projects teams in developing new formulation concepts and designing the best project strategy for our clients. She is continuously working on the improvement of Coriolis' scientific processes, scientific knowledge management and training of Coriolis’ staff.

Andrea values Coriolis Pharma for the opportunity to work with our clients from all over the world on the development of very exciting and novel biopharmaceutical drug products. She is also passionate about creating a positive and motivating working environment, where the contribution of each team member is encouraged to shape the future of Coriolis

Her background is as a pharmacist with a PhD in Pharmaceutical Technology from the LMU Munich. After her PhD thesis, she continued her career as a postdoctoral scientist at the Leiden Academic Center for Drug Research (LACDR) in Leiden (The Netherlands) and was awarded a Veni grant (NWO, The Netherlands) to develop novel approaches for aggregate analysis. She joined Coriolis from the very beginning as member of the founding team, and has been supporting the company since 2008.